Testing effectiveness (Phase 2)Looking for participantsNCT04927338What this trial is testingStudy of Bacopa in Gulf War Illness PatientsWho this might be right forGulf War Illness Nova Southeastern University 170
Large-scale testing (Phase 3)Active Not RecruitingNCT03984448What this trial is testingTesting the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell LymphomasWho this might be right forDiffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDouble-Expressor Lymphoma+5 more National Cancer Institute (NCI) 363
Post-approval studies (Phase 4)Study completedNCT01196078What this trial is testingTarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 114
Large-scale testing (Phase 3)Study completedNCT00441285What this trial is testingNeurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ)Who this might be right forNeurocysticercosisEpilepsy Universidad Peruana Cayetano Heredia 156
Testing effectiveness (Phase 2)Study completedNCT01059643What this trial is testingA Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckWho this might be right forOvarian CancerNon Small Cell Lung CancerProstate Cancer+4 more Eli Lilly and Company 103
Testing effectiveness (Phase 2)Looking for participantsNCT06667908What this trial is testingJNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non-Small-Cell Lung Johnson & Johnson Enterprise Innovation Inc. 130
Testing effectiveness (Phase 2)Study completedNCT00250068What this trial is testingStudy of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)Who this might be right forLung DiseasesCancer University of New Mexico 8
Not applicableWithdrawnNCT01434550What this trial is testingPhase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic CancerWho this might be right forPancreatic Tumor H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06161818What this trial is testingTotal Neoadjuvant Therapy for Lymph Node-positive Adenocarcinoma of the OESophagus and Oesophagogastric JunctionWho this might be right forEsophageal CancerAdenocarcinoma of the Esophagus Erasmus Medical Center 216
Testing effectiveness (Phase 2)Study completedNCT02946190What this trial is testingThe PertADO Geneva TrialWho this might be right forPertussis Siegrist Claire-Anne 60
Testing effectiveness (Phase 2)Ended earlyNCT00845910What this trial is testingCirculating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 22
Testing effectiveness (Phase 2)WithdrawnNCT04495010What this trial is testingNeoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma ParticipantsWho this might be right forMelanoma Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00677248What this trial is testingLDL-Cholesterol Lowering Effect of KB2115 as Add on to EzetimibeWho this might be right forHypercholesterolemia Karo Bio AB 120
Testing effectiveness (Phase 2)UnknownNCT02919878What this trial is testingNeo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal CancerWho this might be right forRectal Adenocarcinoma King Faisal Specialist Hospital & Research Center 25
Testing effectiveness (Phase 2)Study completedNCT00065143What this trial is testingClofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeWho this might be right forLeukemia, MyeloidMyelodysplastic Syndromes M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06920043What this trial is testingEfimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHWho this might be right forMetabolic Dysfunction-Associated SteatohepatitisNon-alcoholic Fatty Liver Disease GlaxoSmithKline 42
Early research (Phase 1)Not Yet RecruitingNCT07787650What this trial is testingS-606001 as Monotherapy in Participants With Late-onset Pompe Disease (LOPD)Who this might be right forPompe Disease Shionogi 15
Testing effectiveness (Phase 2)Ended earlyNCT00538291What this trial is testingCetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan TreatmentWho this might be right forColorectal Cancer City of Hope Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT02044874What this trial is testingEvaluate the Effect of Lorcaserin Hydrochloride on Smoking CessationWho this might be right forSmoking Cessation Arena Pharmaceuticals 603
Testing effectiveness (Phase 2)UnknownNCT05325190What this trial is testingGranisetron Transdermal Patch System for Prevention of CINV by CapeOXWho this might be right forChemotherapy-induced Nausea and Vomiting Tianjin Medical University Cancer Institute and Hospital 57